Relatives in protective gear carry the body of a victim who died from the Chinese Communist virus during a funeral procession in Srinagar, India, May 7, 2021.
Sources close to the matter recently revealed that Indian pharmaceutical companies have recently seen a 300 percent increase in the price of anti-Communist virus (Wuhan pneumonia) drugs purchased from the mainland, and India urged the Communist Party to stabilize the price of raw materials.
In recent times, India has been hit hard by the Chinese Communist virus plague, with the death toll still at around 4,000 on the 15th. As the plague spreads in the country, India’s demand for plague-related drugs and APIs has surged.
According to sources quoted by India’s Economic Times on May 16, a drug that has proven to help reduce mortality rates among plague patients is also the API used to make the anti-parasitic drug ivermectin (an API used to produce various types of preparations, which are active ingredients in preparations, prepared by chemical synthesis, plant extracts or biotechnology, various powders, crystals, infusions, etc. used for medicinal purposes, but which cannot be taken directly by patients). But the patient can not directly take the substance), its price has recently increased by 300%, while Indian pharmaceutical companies from China to purchase almost 70% of the API.
The Indian government has urged the Chinese Communist authorities to stabilize the price of APIs and allow cargo planes to fly without interference, the report said.
After the global outbreak of the plague, the Chinese Communist Party exported large quantities of epidemic prevention masks and other epidemic prevention supplies to Europe, the United States and Canada, Africa and Asian countries, but a large number of masks produced on the mainland were revealed to be substandard.
Recent Comments